- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-CAMLG/CAML antibody (AB236655)
HepG2 (human liver hepatocellular carcinoma cell line) cells stained for CAMLG/CAML (green) using ab236655 at 1/100 dilution in ICC/IF. Secondary antibody is Alexa Fluor® 488-congugated Goat Anti-Rabbit IgG (H+L).
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CAMLG contributes to proper cellular signaling and function by managing calcium flux. It is part of larger protein complexes that regulate calcium-dependent cellular activities. CAMLG assists in the modulation of intracellular calcium levels that influence processes like cell proliferation differentiation and apoptosis. As part of its complex interactions CAMLG collaborates with other proteins involved in calcium signal transduction.
Pathways
Cellular calcium homeostasis mechanisms feature CAMLG as a critical component. This protein functions within pathways such as the NFAT (nuclear factor of activated T-cells) signaling and IP3 (inositol 145-trisphosphate) pathway. In these systems CAMLG interacts with other proteins like IP3 receptor affecting the release and regulation of calcium ions which impact gene transcription and immune response.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Alternative Names
Publications (1)
Recent publications for all applications. Explore the full listand refine your search
Cell reports. Medicine 5:101667 PubMed39106867
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com